SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-18-007677
Filing Date
2018-11-07
Accepted
2018-11-07 08:02:00
Documents
46
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_110718p.htm 10-Q 894740
2 EXHIBIT 31.1 exh_311.htm EX-31.1 11773
3 EXHIBIT 31.2 exh_312.htm EX-31.2 11739
4 EXHIBIT 32.1 exh_321.htm EX-32.1 6716
  Complete submission text file 0001171843-18-007677.txt   3053695

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE prto-20180930.xml EX-101.INS 483601
6 XBRL SCHEMA FILE prto-20180930.xsd EX-101.SCH 31469
7 XBRL CALCULATION FILE prto-20180930_cal.xml EX-101.CAL 25007
8 XBRL DEFINITION FILE prto-20180930_def.xml EX-101.DEF 201059
9 XBRL LABEL FILE prto-20180930_lab.xml EX-101.LAB 188988
10 XBRL PRESENTATION FILE prto-20180930_pre.xml EX-101.PRE 218197
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36694 | Film No.: 181164765
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1